Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2009
10/28/2009EP2112168A1 Use of thermostable biotin-binding protein and solid support having the protein bound thereto
10/28/2009EP2112167A2 Humanized ANTI-ERBB2 antibodies and treatment with ANTI-ERBB2 antibodies
10/28/2009EP2112166A2 Human monoclonal antibodies to CTLA-4
10/28/2009EP2112165A2 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
10/28/2009EP2112164A1 Antiviral peptides comprising lipid attachment signals and methods of use
10/28/2009EP2112159A2 Immuno-interactive fragments of the alpha C subunit of inhibin
10/28/2009EP2111870A1 Dosages for treatment of anti-erbB2 antibodies
10/28/2009EP2111415A2 Monoclonal agonistic anti-ctla-4 antibodies
10/28/2009EP1899378B1 Il-1 beta binding antibodies and fragments thereof
10/28/2009EP1501538B1 Use of alpha-s2 casein precursor-derived peptides
10/28/2009EP1474120B1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
10/28/2009EP1436003B1 Taci-immunoglobulin fusion proteins
10/28/2009EP1098908B1 Anti-ccr2 antibodies and methods of use therefor
10/28/2009EP1071758B1 Porcine adenovirus vector
10/28/2009EP0983361B1 Bacterial pheromones and uses therefor
10/28/2009EP0787181B1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
10/28/2009CN101568349A Methods of reducing phosphate absorption
10/28/2009CN101565726A Process for preparing antibody for small molecular substance using nanoliposome immune adjuvant
10/28/2009CN101565690A Enrofloxacin monoclonal antibody and application
10/28/2009CN101565465A Surface antigen 1 of Toxoplasma gondii human antibody Fab fragment and encoded gene thereof
10/28/2009CN101565464A ELISA kit for rapidly testing melamine content and method thereof
10/28/2009CN101565459A Streptococcus pneumoniae proteins and nucleic acid molecules
10/28/2009CN101564534A Specific yolk antibody preparation for controlling halitosis pathogens and application thereof
10/28/2009CN100554964C Cancer diagnosing agent comprising anti-GPC3 antibody and diagnosis reagent kit
10/28/2009CN100554416C Hybridomas, monoclonal antibody and method for making same and usage thereof
10/28/2009CN100554278C Human tumor M2-type pyruvate kinase antigen determinant polypeptide and antibody and their application in diagnositic kit
10/27/2009USRE40948 APC antibodies
10/27/2009US7608749 Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation
10/27/2009US7608701 Corticotropin releasing factor 2 receptor agonists
10/27/2009US7608698 Muscular disorders; cardiovascular disorders; cell transformed with nucleic acid; culture product
10/27/2009US7608696 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
10/27/2009US7608694 Neutralizing antibody with specificity for antigenic determinants; infections (viral, bacterial, fungal and parasitic), endotoxic shock associtated with infection, arthritis, rheumatoid arthritis, pelvic inflammatory disease, Alzheimer's Disease, Crohn's disease
10/27/2009US7608693 Cytokine specific immunoglobulin for use in diagnosis, prevention and treatment ,of cell proliferative, inflammatory, allergic, respiratory, autoimmune and arthritic disorders
10/27/2009US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009US7608690 IL-B30 antibodies
10/27/2009US7608686 Ztnfr12 polypeptides and Ztnfr12 fusion proteins
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608682 Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates
10/27/2009US7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds
10/27/2009US7608453 Intracellular antibodies
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608451 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells
10/27/2009US7608429 Methods and compositions for increasing antibody production
10/27/2009US7608411 Prostaglandin receptor EP1
10/27/2009US7608409 Screening assay using G-protein coupled receptor protein OT7T175
10/27/2009US7608401 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/27/2009US7608276 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection
10/27/2009US7608269 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
10/27/2009US7608266 Yersinia species compositions
10/27/2009US7608265 Antibody or antigen binding fragment that binds acetyl-coA-acetyltransferase of Clostridium difficile
10/27/2009US7608264 Monoclonal antibody or antibody fragment which binds a pleiotrophin-binding fragment of human Anaplastic Lymphoma Kinase (ALK) and inhibits a pleiotrophin-mediated activity; prevents pleiotrophin-mediated neoplastic or mitogenic activity
10/27/2009US7608263 RG1 antibodies and uses thereof
10/27/2009US7608262 Such as antibodies; treating acute mycocardial infarction, deep vein thrombosis, stroke and thrombophlebitis
10/27/2009US7608260 Stabilized immunoglobulins
10/27/2009CA2328904C Novel (poly)peptides which represent the epitopes of the human herpesvirus type 8
10/26/2009WO2006111524A2 Il-21 variants
10/22/2009WO2009129538A2 Human equivalent monoclonal antibodies engineered from nonhuman variable regions
10/22/2009WO2009129247A2 Sequence diversity generation in immunoglobulins
10/22/2009WO2009129173A2 Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
10/22/2009WO2009128963A2 Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof
10/22/2009WO2009127881A1 Anti-areg/hb-egf antibodies and treatment
10/22/2009WO2009127691A1 Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
10/22/2009WO2009127519A1 Compositions comprising antibodies or antibody fragments
10/22/2009WO2009127414A2 Inhibition of angiogenesis and tumor metastasis
10/22/2009WO2009127046A1 Prostate specific membrane antigen antibodies and antigen binding fragments
10/22/2009WO2009106773A3 Transgenic mice for the c gamma gene human class-g immunoglobulins
10/22/2009WO2009097017A3 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof
10/22/2009WO2009089295A3 Anti-hiv domain antibodies and method of making and using same
10/22/2009WO2009081201A3 BINDING MEMBERS FOR INTERLEUKIN-4 RECEPTOR ALPHA (IL-4Rα) - 173
10/22/2009WO2009041832A9 Vaccines and vaccine components for inhibition of microbial cells
10/22/2009WO2008099071A8 Monoclonal antibody directed against the human ldl receptor
10/22/2009US20090265816 Isolated nucleic acid molecules from the genome of citrus leprosis virus and uses thereof
10/22/2009US20090265815 Sequence-determined DNA fragments and corresponding polypeptides encoded therapy
10/22/2009US20090265797 Novel Anti-IGF-IR Antibodies and Uses Thereof
10/22/2009US20090264631 Immunoadsorption of anti-von willebrand factor cleaving protease antibodies
10/22/2009US20090264628 Crystal structure of human urokinase plasminogen activator amino teminal fragment bound to its receptor
10/22/2009US20090264627 Increasing half-life of immunoglobulin fusion via alteration of carboxy-terminal with cytokine protein; directed protein evolution; antitumor agents
10/22/2009US20090264624 Human cytokine receptor
10/22/2009US20090264618 Compounds With a Branched Linker
10/22/2009US20090264507 Method of diagnosing gum disease-wound healing using single nucleotide polymorphism profiles
10/22/2009US20090264381 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/22/2009US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264361 Identification of a family of secreted proteins in vascular endothelium
10/22/2009US20090264360 Cloning and expression of gonadotropin-releasing hormone (GnRH) receptors
10/22/2009US20090264349 CD30 Ligand
10/22/2009US20090263916 Antagonists of HMG1 for treating inflammatory conditions
10/22/2009US20090263894 Antibodies that bind to mammalian ngal and uses thereof
10/22/2009US20090263883 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
10/22/2009US20090263879 Immunoassay for specific determination of S-adenosylmethionine and analogs thereof in biological samples
10/22/2009US20090263865 Substance Specific to Human PD-1
10/22/2009US20090263864 Recombinant production of mixtures of antibodies
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263840 Novel Monoclonal Anitbody and Use thereof
10/22/2009US20090263832 Reagents for the Detection of Protein Phosphorylation in Leukemia Signaling Pathways
10/22/2009US20090263824 Detection of Neurodegenerative Disease
10/22/2009US20090263823 Glyceroglycolipid antigen of mycoplasma pneumoniae
10/22/2009US20090263785 Modified HIV-1 Peptides and Use Thereof in the Detection of Anit-HIV Antibodies
10/22/2009US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
10/22/2009US20090263417 Multi-subtype FIV vaccines